Establishment Labs (ESTA) another 1000 February $50/$70 call spreads bought, keeps seeing upside call spreads into this ugly sell-off. JPM started Overweight with $75 target late August citing near-term catalysts like the impending launch of Motiva in the U.S. and China, two of the largest markets by volume and dollars for breast augmentation and reconstruction. Citi also a positive catalyst watch seeing China market approval as a key growth driver